Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: Comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission

Blood

Volumn 116, Issue 20, 2010, Pages 4368-4375

  Nishiwaki, Satoshi ^a   Inamoto, Yoshihiro ^b   Sakamaki, Hisashi ^c   Kurokawa, Mineo ^d   Iida, Hiroatsu ^e   Ogawa, Hiroyasu ^f   Fukuda, Takahiro ^g   Ozawa, Yukiyasu ^a   Kobayashi, Naoki ^h   Kasai, Masanobu ⁱ   Mori, Takehiko ^j   Iwato, Koji ^k   Yoshida, Takashi ^l   Onizuka, Makoto ^m   Kawa, Keisei ⁿ   Morishima, Yasuo ⁿ   Suzuki, Ritsuro ^o   Atsuta, Yoshiko ^o   Miyamura, Koichi ^a  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^e Meitetsu Hospital   (Japan)

^f HYOGO COLLEGE OF MEDICINE   (Japan)

^g NATIONAL CANCER CENTER   (Japan)

^h SAPPORO HOKUYU HOSPITAL   (Japan)

ⁱ NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^j KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^l TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^m TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ Japan Marrow Donor Program   (Japan)

^o Japan Society for Hematopoietic Cell Transplantation   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; LEUKOCYTE ANTIGEN; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CYTOGENETICS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HLA MATCHING; HUMAN; HUMAN CELL; KARYOTYPE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RISK FACTOR; SECOND CANCER; SURVIVAL RATE; WHOLE BODY RADIATION;

EID: 78549296784     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-02-269571     Document Type: Article

References (29)

1. Mattison RJ, Larson RA. Role of allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemia. Curr Opin Oncol. 2009;21(6):601-608.
2. Yanada M, Naoe T, Iida H, et al. Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease. Bone Marrow Transplant. 2005;36(10):867-872. (Pubitemid 41655612)
3. Goldstone AH, Richards SM, Lazarus HM, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood. 2008;111(4):1827- 1833.
4. Marks DI, Perez WS, He W, et al. Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood. 2008;112(2):426-434.
5. Kiehl MG, Kraut L, Schwerdtfeger R, et al. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol. 2004;22(14):2816-2825. (Pubitemid 41079899)
6. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15(6):825-828.
7. Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57(2):267-276.
8. Takeuchi J, Kyo T, Naito K, et al. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study. Leukemia. 2002;16(7):1259-1266.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations J Am Stat Assoc. 1958;53:457-481.
10. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A. 1972;135:185-207.
11. Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695-706.
12. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant. 2007;40(4):381-387. (Pubitemid 47202424)
13. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
14. Yakoub-Agha I, Mesnil F, Kuentz M, et al. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol. 2006;24(36):5695-5702.
15. Eapen M, Logan BR, Confer DL, et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant. 2007;13(12):1461-1468.
16. Oh H, Loberiza FR Jr, Zhang MJ, et al. Comparison of graft-versus-host- disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood. 2005;105(4):1408-1416. (Pubitemid 40223655)
17. Baker KS, Loberiza FR Jr, Yu H, et al. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. J Clin Oncol. 2005;23(28):7032-7042.
18. Lee S, Cho BS, Kim SY, et al. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2007;13(9):1083-1094. (Pubitemid 47215565)
19. Cornelissen JJ, Carston M, Kollman C, et al. Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome. Blood. 2001;97(6):1572-1577.
20. Weiner RS, Bortin MM, Gale RP, et al. Interstitial pneumonitis after bone marrow transplantation: assessment of risk factors. Ann Intern Med. 1986;104(2):168-175.
21. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation: Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341(1):14-21.
22. Santo Tomas LH, Loberiza FR Jr, Klein JP, et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest. 2005;128(1):153-161.
23. Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28(5):425-434. (Pubitemid 33069620)
24. Sullivan KM, Shulman HM. Chronic graft-versus-host disease, obliterative bronchiolitis, and graft-versus-leukemia effect: case histories. Transplant Proc. 1989;21(3)[suppl 1]:51-62.
25. Camus P, Fanton A, Bonniaud P, et al. Interstitial lung disease induced by drugs and radiation. Respiration. 2004;71(4):301-326. (Pubitemid 39179164)
26. Bacigalupo A, Lamparelli T, Gualandi F, et al. Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcome. Bone Marrow Transplant. 2007;39(6):341-346.
27. Fung HC, Stein A, Slovak M, et al. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome. Biol Blood Marrow Transplant. 2003;9(12):766-771.
28. Forman SJ, Schmidt GM, Nademanee AP, et al. Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia. J Clin Oncol. 1991;9(9):1570-1574.
29. Mehta J. Hematopoietic stem cell transplantation from unrelated donors for acute leukemia. Blood. 2008;112:447-448.